Benzodiazepine is under investigation for the prevention of Delirium and C.Surgical Procedure; Cardiac. Benzodiazepine has been investigated for the treatment of Obesity, Sleep Apnea, Obstructive, and Disorders of Gallbladder, Biliary Tract and Pancrease.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | 1,2-Benzodiazepine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of 1,2-Benzodiazepine. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of 1,2-Benzodiazepine. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of 1,2-Benzodiazepine. |
| Hydrocodone | 1,2-Benzodiazepine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of 1,2-Benzodiazepine. |
| Magnesium sulfate | The therapeutic efficacy of 1,2-Benzodiazepine can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | 1,2-Benzodiazepine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | 1,2-Benzodiazepine may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of 1,2-Benzodiazepine. |
| Mirtazapine | 1,2-Benzodiazepine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of 1,2-Benzodiazepine. |
| Orphenadrine | 1,2-Benzodiazepine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | 1,2-Benzodiazepine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of 1,2-Benzodiazepine. |
| Pramipexole | 1,2-Benzodiazepine may increase the sedative activities of Pramipexole. |
| Ropinirole | 1,2-Benzodiazepine may increase the sedative activities of Ropinirole. |
| Rotigotine | 1,2-Benzodiazepine may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with 1,2-Benzodiazepine. |
| Suvorexant | 1,2-Benzodiazepine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of 1,2-Benzodiazepine. |
| Thalidomide | 1,2-Benzodiazepine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | 1,2-Benzodiazepine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Clozapine | The risk or severity of adverse effects can be increased when 1,2-Benzodiazepine is combined with Clozapine. |
| Methadone | 1,2-Benzodiazepine may increase the central nervous system depressant (CNS depressant) activities of Methadone. |
| Olanzapine | The risk or severity of adverse effects can be increased when 1,2-Benzodiazepine is combined with Olanzapine. |
| Sodium oxybate | 1,2-Benzodiazepine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Teduglutide | The serum concentration of 1,2-Benzodiazepine can be increased when it is combined with Teduglutide. |
| Ethanol | 1,2-Benzodiazepine may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | 1,2-Benzodiazepine may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of 1,2-Benzodiazepine. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when 1,2-Benzodiazepine is combined with Fluvoxamine. |
| Citalopram | The risk or severity of adverse effects can be increased when 1,2-Benzodiazepine is combined with Citalopram. |
| Duloxetine | The risk or severity of adverse effects can be increased when 1,2-Benzodiazepine is combined with Duloxetine. |
| Trazodone | The risk or severity of adverse effects can be increased when 1,2-Benzodiazepine is combined with Trazodone. |
| Paroxetine | The risk or severity of adverse effects can be increased when 1,2-Benzodiazepine is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when 1,2-Benzodiazepine is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when 1,2-Benzodiazepine is combined with Sibutramine. |
| Escitalopram | The risk or severity of adverse effects can be increased when 1,2-Benzodiazepine is combined with Escitalopram. |
| Zimelidine | The risk or severity of adverse effects can be increased when 1,2-Benzodiazepine is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when 1,2-Benzodiazepine is combined with Dapoxetine. |
| Milnacipran | The risk or severity of adverse effects can be increased when 1,2-Benzodiazepine is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when 1,2-Benzodiazepine is combined with Desvenlafaxine. |
| Seproxetine | The risk or severity of adverse effects can be increased when 1,2-Benzodiazepine is combined with Seproxetine. |
| Indalpine | The risk or severity of adverse effects can be increased when 1,2-Benzodiazepine is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when 1,2-Benzodiazepine is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when 1,2-Benzodiazepine is combined with Alaproclate. |
| Cyproheptadine | The risk or severity of CNS depression can be increased when Cyproheptadine is combined with 1,2-Benzodiazepine. |
| Amoxapine | The risk or severity of CNS depression can be increased when Amoxapine is combined with 1,2-Benzodiazepine. |
| Propiomazine | The risk or severity of CNS depression can be increased when Propiomazine is combined with 1,2-Benzodiazepine. |
| Maprotiline | The risk or severity of CNS depression can be increased when Maprotiline is combined with 1,2-Benzodiazepine. |
| Desipramine | The risk or severity of CNS depression can be increased when Desipramine is combined with 1,2-Benzodiazepine. |
| Pizotifen | The risk or severity of CNS depression can be increased when Pizotifen is combined with 1,2-Benzodiazepine. |
| Dosulepin | The risk or severity of CNS depression can be increased when Dosulepin is combined with 1,2-Benzodiazepine. |
| Amitriptyline | The risk or severity of CNS depression can be increased when Amitriptyline is combined with 1,2-Benzodiazepine. |
| Imipramine | The risk or severity of CNS depression can be increased when Imipramine is combined with 1,2-Benzodiazepine. |
| Nortriptyline | The risk or severity of CNS depression can be increased when Nortriptyline is combined with 1,2-Benzodiazepine. |
| Nicardipine | The metabolism of 1,2-Benzodiazepine can be decreased when combined with Nicardipine. |
| Doxepin | The risk or severity of CNS depression can be increased when Doxepin is combined with 1,2-Benzodiazepine. |
| Quetiapine | The risk or severity of CNS depression can be increased when Quetiapine is combined with 1,2-Benzodiazepine. |
| Zopiclone | The risk or severity of adverse effects can be increased when 1,2-Benzodiazepine is combined with Zopiclone. |
| Caffeine | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with Caffeine. |
| Dyphylline | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with Dyphylline. |
| Pentoxifylline | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with Pentoxifylline. |
| Mercaptopurine | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with Mercaptopurine. |
| Oxtriphylline | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with Oxtriphylline. |
| Theobromine | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with Theobromine. |
| Fenethylline | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with Fenethylline. |
| 8-azaguanine | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with 8-azaguanine. |
| 7,9-Dimethylguanine | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with 7,9-Dimethylguanine. |
| Xanthine | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with Xanthine. |
| 7-Deazaguanine | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with 7-Deazaguanine. |
| Guanine | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with Guanine. |
| 9-Methylguanine | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with 9-Methylguanine. |
| Peldesine | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with Peldesine. |
| Hypoxanthine | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with Hypoxanthine. |
| 9-Deazaguanine | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with 9-Deazaguanine. |
| Propentofylline | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with Propentofylline. |
| Valomaciclovir | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with Valomaciclovir. |
| 3-isobutyl-1-methyl-7H-xanthine | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with 3-isobutyl-1-methyl-7H-xanthine. |
| Uric acid | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with Uric acid. |
| Doxofylline | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with Doxofylline. |
| 6-O-benzylguanine | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with 6-O-benzylguanine. |
| Lisofylline | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with Lisofylline. |
| Lobucavir | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with Lobucavir. |
| Cafedrine | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with Cafedrine. |
| Theodrenaline | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with Theodrenaline. |
| Bamifylline | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with Bamifylline. |
| Proxyphylline | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with Proxyphylline. |
| Acefylline | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with Acefylline. |
| Etamiphylline | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with Etamiphylline. |
| Pentifylline | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with Pentifylline. |
| Bufylline | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with Bufylline. |
| Bromotheophylline | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with Bromotheophylline. |
| Furafylline | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with Furafylline. |
| 8-chlorotheophylline | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with 8-chlorotheophylline. |
| PCS-499 | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with PCS-499. |
| Theophylline | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with Theophylline. |
| Aminophylline | The therapeutic efficacy of 1,2-Benzodiazepine can be decreased when used in combination with Aminophylline. |
| Botulinum toxin type B | The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with 1,2-Benzodiazepine. |